🧪 UPDATED DAILY FROM CLINICALTRIALS.GOVSynced Apr 1

Find Clinical Trials for Your Rare Disease

84+ recruiting trials across all rare diseases. Filter by phase, location, and condition.

Clinical trial records are synced from ClinicalTrials.gov.
Report missing data
Clear

Showing 20 of 84 recruiting trials for “sickle-cell-anemia

RecruitingNCT05170412

Dietary Intake and Dietary Behaviors in Adults With Sickle Cell Disease

👨‍⚕️ Nicole M Farmer, M.D., National Institutes of Health Clinical Center (CC)📍 1 site📅 Started May 2022View details ↗
NARecruitingNCT05210114

Cutaneous Hydration Assessment in SCD

👨‍⚕️ Enrico Novelli, MD, University of Pittsburgh📍 1 site📅 Started Jan 2022View details ↗
RecruitingNCT06213402

RADeep Multicenter European Epidemiological Platform for Patients Diagnosed With Rare Anemia Disorders (RADs)

👨‍⚕️ María del Mar Manú Pereira, PhD, Vall d'hebron Research Institute - Vall d'Hebron Research Institute - University Hospital Vall d'Hebrón (VHIR/HUVH)📍 1 site📅 Started Nov 2021View details ↗
Phase 2RecruitingNCT05012631

Losartan for Diffuse Myocardial Fibrosis in Sickle Cell Disease

🏥 Children's Hospital Medical Center, Cincinnati📍 1 site📅 Started Sep 2021View details ↗
Phase 2RecruitingNCT04201210

A Trial to Assess Haploidentical T-depleted Stem Cell Transplantation in Patients With SCD

👨‍⚕️ Selim Corbacioglu, MD, University Hospital of Regensburg📍 9 sites📅 Started Jun 2021View details ↗
NARecruitingNCT04484272

A Stress and Pain Self-management m-Health App for Adult Outpatients With Sickle Cell Disease

👨‍⚕️ Miriam O. Ezenwa, University of Florida📍 1 site📅 Started Apr 2021View details ↗
Phase 3Enrolling by InvitationNCT04208529

A Long-term Follow-up Study in Participants Who Received CTX001

🏥 Vertex Pharmaceuticals Incorporated📍 20 sites📅 Started Jan 2021View details ↗
RecruitingNCT04416178

Sickle Cell Disease and the Genomic and Gene Therapy Needs of Stakeholders

👨‍⚕️ Liza M. Johnson, MD, MPH, MSB, St. Jude Children's Research Hospital📍 1 site📅 Started Dec 2020View details ↗
Enrolling by InvitationNCT04628585

Long-term Follow-up of Subjects with Sickle Cell Disease Treated with Ex Vivo Gene Therapy

👨‍⚕️ Anjulika Chawla, MD, bluebird bio, Inc.📍 16 sites📅 Started Oct 2020View details ↗
NARecruitingNCT04688411

An mHealth Strategy to Improve Medication Adherence in Adolescents With Sickle Cell Disease

👨‍⚕️ Sherif M. Badawy, MD, MS, Ann & Robert H Lurie Children's Hospital of Chicago📍 1 site📅 Started Sep 2020View details ↗
NARecruitingNCT03976180

High-flow Oxygen for Vaso-occlusive Pain Crisis

👨‍⚕️ Armand Mekontso, Assistance Publique - Hôpitaux de Paris📍 1 site📅 Started Apr 2020View details ↗
Phase 1RecruitingNCT04055818

A Study of Nicotinamide With Oral Tetrahydrouridine and Decitabine to Treat High Risk Sickle Cell Disease

👨‍⚕️ Robert Molokie, University of Illinois at Chicago College of Medicine📍 1 site📅 Started Jan 2020View details ↗
Phase 2Enrolling by InvitationNCT03948867

Stroke Prevention With Hydroxyurea Enabled Through Research and Education (SPHERE)

🏥 Children's Hospital Medical Center, Cincinnati📍 2 sites📅 Started Apr 2019View details ↗
RecruitingNCT03685721

Genotype -Phenotype Correlation of PKLR Variants With Pyruvate Kinase, 2,3-Diphosphglycerate and Adenosine Triphosphate Activities in Red Blood Cells of People With Sickle Cell Disease

👨‍⚕️ Swee Lay Thein, M.D., National Heart, Lung, and Blood Institute (NHLBI)📍 1 site📅 Started Oct 2018View details ↗
RecruitingNCT05376046

Study of Erythrocyte Parameters and Hypercoagulability in Sickle Cell Disease (SCD-TGA)

🏥 BILLOIR📍 1 site📅 Started Sep 2018View details ↗
Phase 1RecruitingNCT03653338

T-Cell Depleted Alternative Donor Bone Marrow Transplant for Sickle Cell Disease (SCD) and Other Anemias

👨‍⚕️ Paul Szabolcs, MD, University of Pittsburgh📍 1 site📅 Started Aug 2018View details ↗
Phase 2RecruitingNCT03587272

Minimizing Toxicity in HLA-identical Sibling Donor Transplantation for Children With Sickle Cell Disease

👨‍⚕️ Robert Nickel, MD, Children's National Research Institute📍 7 sites📅 Started Apr 2018View details ↗
NARecruitingNCT03353584

Effect of Virtual Reality Technology for Pain Management of Vaso-Occlusive Crisis in Patients With Sickle Cell Disease

👨‍⚕️ Michael Frett, MD, St. Jude Children's Research Hospital📍 2 sites📅 Started Feb 2018View details ↗
Phase 2RecruitingNCT02675959

Myeloablative Conditioning, Prophylactic Defibrotide and Haplo AlloSCT for Patients With Sickle Cell Disease

👨‍⚕️ Mitchell Cairo, MD, New York Medical College📍 4 sites📅 Started Jul 2017View details ↗
Phase 1, PHASE2RecruitingNCT03128996

Reduced Intensity Conditioning and Familial HLA-Mismatched BMT for Non-Malignant Disorders

👨‍⚕️ Shalini Shenoy, MD, Washington University School of Medicine📍 4 sites📅 Started Mar 2017View details ↗
← PreviousPage 4 of 5Next →

Get alerts when new trials open

Create a free account to follow conditions and receive trial notifications.

Create free account →